Partner药物洗脱支架在急诊经皮冠状动脉介入治疗中的临床疗效  

The clinical outcomes of Partner drug-eluting stent in emergent PCI

作　　者：安健[1] 李保[1] 杨滨[1] 王敬萍[1] 张悟堂[1] 王仲朝[1] 王慧仙[1] 芦丽芳[1] 高勇莉[1] 

机构地区：[1]山西省心血管疾病医院心内科,太原030024

出　　处：《中国药物与临床》2009年第9期806-807,共2页Chinese Remedies & Clinics

基　　金：山西省卫生厅科技攻关计划项目(041081)

摘　　要：目的观察Partner药物洗脱支架在急诊经皮冠状动脉介入治疗(PCI)中的临床疗效。方法选择行急诊PCI的患者68例,分为Partner支架组和Cypher支架组,比较PCI术后即刻最小管腔直径,术后6个月复查冠状动脉造影,比较两组患者的再狭窄率。结果Partner支架组术后即刻最小管腔直径为(3.1±0.8)mm,Cypher支架组为(3.1±0.3)mm,两组相比差异无统计学意义(P>0.05);6个月冠状动脉造影显示再狭窄率Partner支架组为4%,Cypher支架组为3%,两组相比差异无统计学意义。结论在急诊PCI中,应用Partner药物洗脱支架安全有效。Objective To investigate the short-term outcomes of Partner drug-eluting stents in patients who were referred for emergent percutaneous coronary intervention. Methods Among 68 patients referred for emergent percutaneous coronary intervention, thirty-six were implanted with Partner stents and 32 with Cypher stents. Minimum lumen diameter （MLD） immediately after procedure and rates of re-stenosis at follow-up coronary angiography after 6 months were compared between the two cohorts. Results There were no statistical differences between the two cohorts in terms of MLD [（3.1±0.8）mm in Partner group vs （3.1±0.3）mm in Cypher group, P〉0.05 ] and rates of restenosis （4% in Partner group vs 3% in Cypher group, P〉0.05）. Conclusion Partner drug-eluting stents appeared safe and effective for use in emergent PCI.

关 键 词：支架 血管成形术经腔 经皮冠状动脉 急诊处理 

分 类 号：R541.4[医药卫生—心血管疾病]